What the record shows
Paradigm Peptides, the storefront of Paradigm R.E. LLC of Bourbonnais, Illinois, no longer exists. Its homepage returns HTTP 403, and CBS News reports that the business shut down in March 2024. Everything in this report comes from FDA, Department of Justice and news sources; the site did not load, and no vendor-published data exists in our record. For once, the absence of a storefront is not the problem. The problem is what the storefront was doing while it was open.
According to the Department of Justice for the Northern District of Indiana, owner Matthew Kawa pleaded guilty on December 10, 2025 and was sentenced on July 30, 2026 to five years and ten months in federal prison. An employee, Jennifer Stechkober, received one year and four months. Prosecutors stated that from April 2019 to March 2024 the company sold unapproved new drugs, including BPC-157 and products marketed as SARMs, imported from China and India, and that the products sold as SARMs contained a hormone that was not what the label described. Per CBS News, Kawa admitted that the company forged laboratory certificates of analysis while advertising 99 percent purity and third-party testing. A $5 million forfeiture was agreed and $78,317.52 in restitution was ordered. Customers were in all 50 states and 80 countries, and products shipped from Michigan City, Indiana.
The regulatory record
The FDA issued a warning letter to Paradigm RE LLC dated December 7, 2020, published at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/paradigm-re-llc-612014-12072020. The letter concerned marketing claims for a product named in the letter, which the FDA described as an unapproved new drug and misbranded. The company traded for more than three years after receiving it, which is worth remembering whenever a supplier’s defenders say a warning letter changes nothing.
The Trustpilot page for paradigmpeptides.com returns HTTP 451. Our record notes that paradigm-peptide.com, which Finnrick describes as a separate, recent, privacy-protected domain, and paradigmpeptides.is now operate under similar names. Neither is the company profiled here, and neither inherits its record in either direction.
If you still see Paradigm Peptides recommended
Older lists and forum posts will carry the name for years, and some will still describe the company as tested and trustworthy. Any such recommendation predates the guilty plea and refers to a company whose certificates, by its owner’s own admission in federal court, were forged. A reader who finds the name on a list should treat the rest of that list with care, because whoever compiled it took the certificates at face value.
Our read
There is nothing to evaluate and no supplier to buy from. What remains is a lesson. Paradigm Peptides advertised 99 percent purity and third-party testing, published certificates to prove it, and traded for five years on those documents, and the documents were fabricated. The record is the clearest example in our file of why a published certificate proves nothing until the issuing laboratory confirms it, and of why we treat a named, accredited laboratory with a verification path as the minimum rather than a bonus.
